Skip to Content

Lorviqua 100 mg film-coated tablet

Licence status
Authorised: 06/05/2019
Active substances
LORLATINIB
Dosage Form
Film-coated tablet
Licence number
EU/1/19/1355/002
Licence holder
Pfizer Europe MA EEIG

Licence information

ATC code
L01 ANTINEOPLASTIC AGENTS, L01XE44 lorlatinib
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
06/05/2019